| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |